Form 4: Voyager Therapeutics COO Robin Swartz Sells Shares to Cover Tax Obligations

Robin Swartz, COO & CBO of Voyager Therapeutics, sold 6,950 shares of common stock to cover tax obligations related to vesting restricted stock units.

Summary

• On February 11, 2025, Robin Swartz, the COO & CBO of Voyager Therapeutics, sold 6,950 shares of the company's common stock.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units on February 9, 2025.
• The shares were sold at a weighted average price of $4.45, with individual transactions ranging from $4.13 to $5.00.
• Following the transaction, Swartz directly owns 102,291 shares of Voyager Therapeutics.
• The sale was not a discretionary trade but rather an automatic sell-to-cover election.

Sentiment

Score: 6

Explanation: The document reflects a neutral event (stock sale for tax purposes). It's a routine transaction and doesn't necessarily indicate positive or negative sentiment towards the company's prospects.

Industry Context

This is a routine transaction related to executive compensation and tax obligations. It is common for executives to sell shares to cover taxes when restricted stock units vest.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to have a significant impact due to the nature of the transaction.

Key Dates